Citigroup Raises Merck & Co. Inc. (NYSE:MRK) Target Price To $ 79.00

Citigroup maintains Merck & Co. Inc. (NYSE:MRK) at Buy rating, while revising the price target. The research firm raises target price to $ 79.00 up from previous mark of $ 70.00.

According to the previous trading day, closing price of MRK was $ 69.46, representing a 31.48 % increase from the 52 week low of $ 52.83 and a 4.71 % decrease over the 52 week high of $ 72.89.

Merck & Co. Inc. has a market capital of $ 186.55 billion and is part of the Healthcare sector and Drug Manufacturers – Major industry.

Be the first to comment

Leave a Reply